Jason Breaux
Analyst · Raymond James
Thank you, Dan. Good morning, everyone. Thank you for joining our earnings call today. We appreciate your continued interest in CCAP. Today, I'll highlight our second quarter results, review our investing activity and current portfolio and then provide some thoughts on the current market backdrop. Gerhard will then review our financial results in more detail. So let's begin. Please turn to Slide 6, where you'll see a summary of our results. We reported adjusted net investment income for the second quarter of $0.41 per share. On a GAAP basis, our second quarter net investment income was $0.50 per share. The difference relates to a $0.09 per share noncash reversal of our capital gains-based incentive fees on net unrealized capital appreciation. Our net asset value per share ended the quarter at $20.69, down just over 2% as compared to the record $21.18 per share, which we reported in the prior quarter. Gerhard will touch on this in more detail, but the lion's share of the decline relates to unrealized losses we took to reflect wider credit spreads in the market as volatility within the leveraged finance and equity markets continued during the second quarter. This volatility has created an increasingly complex operating environment that many companies face in today's economy. However, our continued focus on market-leading companies with strong margins and high free cash flow generation in resilient industries has positioned our portfolio to avoid segments of the economy that are in our view, more negatively impacted by recent inflation and supply chain issues. And while certain of our companies are experiencing some margin pressure from increases in labor and input costs, our portfolio companies have largely been able to maintain solid margins. Our investment philosophy for the past 30-plus years at Crescent has been disciplined credit selection with a focus on capital preservation. It's at the core of Crescent's DNA and has led to investors entrusting us with their capital to successfully originate and manage the low investment-grade debt investments across multiple strategies and over numerous cycles. We believe this approach has resulted in an attractive, highly diversified CCAP portfolio, as highlighted on Slides 13 and 14 of the presentation. We ended the quarter with our second largest portfolio since inception, with nearly $1.3 billion of investments at fair value across 137 portfolio companies with an average investment size of less than 1% of the total portfolio. Our portfolio continues to consist primarily of senior secured first lien and unitranche first lien loans, collectively representing 88% of the portfolio at fair value, up from 86% in the prior quarter. And we remain well diversified across 18 industries and continue to lend almost exclusively to private equity-backed companies, with 98% of our debt portfolio in sponsor-backed companies as of quarter end. For the second quarter, 136 out of our 137 debt investment portfolio companies, representing over 99% of total debt investments at fair value, made full scheduled principal and interest payments. 91% of our debt investment portfolio today is marked above $0.95 on the dollar with an average mark of approximately [97%.] Two more positive credit trends are outlined on Slide 17. Continued strong performance ratings and nonaccrual levels. Our weighted average portfolio grade of 2.1, was unchanged as compared to the prior quarter. And the percentage of risk rated 1 and 2 investments, the highest ratings our portfolio companies can receive, remains healthy at 89% of the portfolio at fair value. As of quarter end, we had investments in 3 portfolio companies on nonaccrual status, representing 1.3% and 1.1% of our total debt investments at cost and fair value, respectively, as compared to 1.4% and 1.2% in the prior quarter. Moving to our investment activity. Please turn back to Slide 15. Gross deployment in the second quarter was $112.4 million, as you can see on the left-hand side of the page, 96% of which was in senior secured first lien and unitranche investments. All told, we closed on 11 new and 12 follow-on investments totaling $8 million and $9 million, respectively, with the remaining $23 million coming from revolver and delayed draw term loan activity. All 11 of the new investments were first lien or unitranche private equity-backed loans with silver floors of 75 to 100 basis points, OIDs of 1% and 2% and a weighted average spread of approximately 590 basis points. In addition, loan-to-value levels remain attractive, averaging 41% for these transactions. The $112 million in gross deployment compares to approximately $97 million in aggregate exits sales and repayments in the quarter. It's also worth highlighting that CCAP's total commitment for the aforementioned new deals represented about 10% of the over $1.1 billion total check size committed across Crescent's private credit accounts, highlighting the breadth of the platform. Moving to the right-hand side of the page, you'll see that over the past several quarters, our net investment activity has led to unitranche first lien becoming a more prominent percentage of our total portfolio. This increase from 46% a year ago to 62% today is by design as it allows us to offer even greater surety of execution to the sponsor community and enables us to enhance our yield opportunity while remaining at the top of the capital stack. We expect this trend will continue, particularly given the wind down of CBDC Senior Loan Fund, our joint venture that I've touched on in prior quarters. To date, we sold roughly 94% of the approximately $300 million pool of first lien broadly syndicated loans within the joint venture and plan to monetize the remaining 6% and formally wind down the entity in the coming months. We made our first liquidating distribution during the second quarter and expect to distribute the remaining proceeds, which were marked at approximately $19 million as of quarter end by the end of this year. A few more items before I turn it over to Gerhard. First, I'd like to highlight the impact of Federal Reserve's rapid interest rate hikes have had and will most likely continue to have on us. As of June 30, 98.7% of our debt investments at fair value were floating rate with a weighted average floor of 83 basis points, which compares to our 72% floating rate liability structure with no floors. This situates us well to benefit from increases in market interest rates above our average floors as was the case this quarter with growth in our interest income line item despite relatively modest net investment activity. If the full impact of the market rate moves this quarter had flowed through the entire quarter, we calculate that our second quarter adjusted net investment income per share would have been $0.07 higher. Additionally, as of quarter end, holding all else equal and after considering the impact of income-based incentive fees, we calculate that a 100 basis point increase in short-term rates could increase our annual earnings by approximately $0.20 per share, which would represent an 11.5% lift to our LTM adjusted net investment income per share. In terms of the impact of rising rates on our debt investments, we continue to believe we've constructed a highly diversified and defensive portfolio. And sitting here today, do not observe any meaningful credit deterioration. Our debt investments ended the quarter with a weighted average interest coverage ratio of 2.7x. Holding all else equal, including leverage at the borrower level, short-term base rates will need to rise by over 2% before aggregate interest coverage would dip below 2x. We feel good about the ability of our portfolio companies to navigate a higher rate environment and have developed a toolkit over Crescent's 30-year operating history to effectively navigate through periods of heightened volatility. Finally, for the third quarter of 2022, our Board declared a $0.41 per share quarterly cash dividend, which will be paid on October 17 to stockholders of record as of September 30. Additionally, the fourth and final previously declared $0.05 per share special cash dividend will be paid on September 15 to stockholders of record as of September 2. So with that, I'll turn the call over to Gerhard to cover some more details on the second quarter. Gerhard?